The global “Polymerase Chain Reaction Market” is expected to reach USD 8.14 billion by 2026, on account of the advent of digitalization and the gradual shift from traditional PCR to digital PCR for diagnostics purposes. PCR is considered the most unique and most widely referred clinical testing technique utilized in modern biology. It includes a molecular technology for the in-vitro amplification of a specific region in a DNA strand.

More information on this market is presented in a recently published report by Fortune Business Insights™ titled, “Polymerase Chain Reaction (PCR) Market Size, Share & Industry Analysis, By Type (Standard PCR, Real-time PCR, and Digital PCR), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026.” As per this report, the market value was USD 4.31 billion in 2018 and will rise at a CAGR of 8.3% between 2019 to 2026.

Major Polymerase Chain Reaction Market Key players covered in the report include:

  • Agilent Technologies, Inc.,
  • Qiagen
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Sysmex Inostics
  • Abbott
  • Thermo Fischer Scientific Inc.
  • Eppendorf AG
  • Other players

Get Request a Sample Copy of the Polymerase Chain Reaction Report:

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Polymerase Chain Reaction Market Analysis 2021:

Regional Segmentation:

North America Dominating Market with Adequate Reimbursement Policies for PCR Devices

As per segmentation by region, North America earned a revenue of USD 1.72 billion in 2018 and contributed the largest polymerase chain reaction market share. Factors attributed to this dominance include the increasing prevalence and diagnosis cases of infectious diseases, the presence of adequate reimbursement policies for PCR devices, and the high number of the patient population adopting new diagnostic procedures. This is being followed by Europe, owing to the increasing incidences of different cancer types and metabolic diseases that require advanced therapies and diagnosis.

Additionally, the Asia Pacific market is likely to witness robust growth during the forecast period on account of the rise in awareness amongst the patient population about the presence of advanced PCR devices, coupled with the presence of a substantial underpenetrated market. Furthermore, the Middle East and Africa and Latin America markets are considered to be in the nascent stage and are likely to witness stable growth in the coming years. This is attributable to the increasing prevalence of genetic and infectious diseases.

For More Information in the Analysis of Reports: